Cargando…
Resistance in tuberculosis: what do we know and where can we go?
Tuberculosis (TB) has become a worldwide threat, mainly due to the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis (Mtb). This mini-review is focused on the various mechanisms of resistance to the currently available anti-TB drugs and...
Autores principales: | Green, Keith D., Garneau-Tsodikova, Sylvie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719028/ https://www.ncbi.nlm.nih.gov/pubmed/23888158 http://dx.doi.org/10.3389/fmicb.2013.00208 |
Ejemplares similares
-
Maternal sleep position: what do we know where do we go?
por: O’Brien, Louise M, et al.
Publicado: (2015) -
Coffee and digestive cancers—what do we know, and where do we go?
por: Loftfield, Erikka, et al.
Publicado: (2020) -
Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go?
por: Aprotosoaie, Ana Clara, et al.
Publicado: (2022) -
Hepatitis of unknown etiology in children: What we know and what we can do?
por: Zhu, Mingyu, et al.
Publicado: (2022) -
The lingering dilemma of arterial pressure in CKD: what do we know, where do we go?
por: Agarwal, Rajiv, et al.
Publicado: (2011)